Search

Your search keyword '"Peterlongo P."' showing total 115 results

Search Constraints

Start Over You searched for: Author "Peterlongo P." Remove constraint Author: "Peterlongo P." Topic female Remove constraint Topic: female
115 results on '"Peterlongo P."'

Search Results

1. A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

2. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

3. Rare germline copy number variants (CNVs) and breast cancer risk

4. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

5. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

6. Two truncating variants in FANCC and breast cancer risk.

7. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

8. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

9. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

10. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

11. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

12. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

13. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

14. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

15. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

16. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

17. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

18. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

19. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

20. RAD51B in Familial Breast Cancer.

21. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

22. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

23. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

24. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

25. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

26. Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

27. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

28. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

29. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

30. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

31. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

32. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

33. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

34. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

35. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

36. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).

37. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

38. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

39. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

40. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

41. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

42. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

43. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

44. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

45. Two truncating variants in FANCC and breast cancer risk

46. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

47. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

48. Body mass index and breast cancer survival: a Mendelian randomization analysis

49. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

50. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

Catalog

Books, media, physical & digital resources